ATE413397T1 - Heterosubstituierte c7-taxanacetate als antitumormittel - Google Patents
Heterosubstituierte c7-taxanacetate als antitumormittelInfo
- Publication number
- ATE413397T1 ATE413397T1 AT01906965T AT01906965T ATE413397T1 AT E413397 T1 ATE413397 T1 AT E413397T1 AT 01906965 T AT01906965 T AT 01906965T AT 01906965 T AT01906965 T AT 01906965T AT E413397 T1 ATE413397 T1 AT E413397T1
- Authority
- AT
- Austria
- Prior art keywords
- heterosubstituted
- taxanacetate
- tumor agents
- texanes
- range
- Prior art date
Links
- 239000002246 antineoplastic agent Substances 0.000 title 1
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical group CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 abstract 1
- 125000002887 hydroxy group Chemical group [H]O* 0.000 abstract 1
- 125000001424 substituent group Chemical group 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D305/00—Heterocyclic compounds containing four-membered rings having one oxygen atom as the only ring hetero atoms
- C07D305/14—Heterocyclic compounds containing four-membered rings having one oxygen atom as the only ring hetero atoms condensed with carbocyclic rings or ring systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
- C07D409/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
- C07D409/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K31/337—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having four-membered rings, e.g. taxol
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
- C07D405/12—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/14—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing three or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D407/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00
- C07D407/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00 containing two hetero rings
- C07D407/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D407/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00
- C07D407/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00 containing three or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
- C07D409/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing three or more hetero rings
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Pharmacology & Pharmacy (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Epidemiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
- Epoxy Compounds (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US17967200P | 2000-02-02 | 2000-02-02 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ATE413397T1 true ATE413397T1 (de) | 2008-11-15 |
Family
ID=22657505
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AT01906965T ATE413397T1 (de) | 2000-02-02 | 2001-02-02 | Heterosubstituierte c7-taxanacetate als antitumormittel |
Country Status (20)
| Country | Link |
|---|---|
| US (3) | US6673833B2 (de) |
| EP (1) | EP1200424B1 (de) |
| JP (1) | JP2003522169A (de) |
| KR (1) | KR20010112393A (de) |
| CN (1) | CN1362957A (de) |
| AT (1) | ATE413397T1 (de) |
| AU (1) | AU776765B2 (de) |
| BR (1) | BR0104353A (de) |
| CA (1) | CA2368534A1 (de) |
| CZ (1) | CZ20013519A3 (de) |
| DE (1) | DE60136430D1 (de) |
| HK (1) | HK1047935A1 (de) |
| HU (1) | HUP0200651A3 (de) |
| IL (1) | IL145642A0 (de) |
| MX (1) | MXPA01009922A (de) |
| NO (1) | NO20014758L (de) |
| NZ (1) | NZ514411A (de) |
| PL (1) | PL350328A1 (de) |
| WO (1) | WO2001057029A1 (de) |
| ZA (1) | ZA200108063B (de) |
Families Citing this family (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2003522169A (ja) * | 2000-02-02 | 2003-07-22 | フロリダ・ステイト・ユニバーシティ・リサーチ・ファウンデイション・インコーポレイテッド | 抗腫瘍剤としてのｃ７ヘテロ置換アセテートタキサン |
| US20040210289A1 (en) * | 2002-03-04 | 2004-10-21 | Xingwu Wang | Novel nanomagnetic particles |
| EP1534674A4 (de) | 2002-08-02 | 2007-11-28 | Immunogen Inc | Zytotoxische mittel, die neue, wirkungsvolle taxane enthalten, und deren therapeutische verwendung |
| US7390898B2 (en) | 2002-08-02 | 2008-06-24 | Immunogen Inc. | Cytotoxic agents containing novel potent taxanes and their therapeutic use |
| US20070149496A1 (en) * | 2003-10-31 | 2007-06-28 | Jack Tuszynski | Water-soluble compound |
| CN1960721A (zh) * | 2004-03-05 | 2007-05-09 | 佛罗里达州立大学研究基金有限公司 | C7乳酰氧基取代的紫杉烷类 |
| US20050249667A1 (en) * | 2004-03-24 | 2005-11-10 | Tuszynski Jack A | Process for treating a biological organism |
| CN1712399B (zh) * | 2004-06-24 | 2010-08-11 | 中国医学科学院药物研究所 | 紫杉醇和免疫增强剂胞壁酰二肽共轭物的制备及用途 |
| US20080081067A1 (en) * | 2006-10-03 | 2008-04-03 | Gupta Manishkumar | Sustained release pharmaceutical compositions of venlafaxine and process for preparation thereof |
| WO2011147330A1 (zh) | 2010-05-27 | 2011-12-01 | 中国医学科学院药物研究所 | 双功能共缀物的化学合成及抗肿瘤与抗肿瘤转移作用 |
Family Cites Families (39)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4879929A (en) * | 1988-06-06 | 1989-11-14 | Roth Alfred C | Tapper/threader assembly |
| US4950790A (en) * | 1988-11-14 | 1990-08-21 | Air Products And Chemicals, Inc. | Volatile fluorinated β-ketoimines and associated metal complexes |
| US4960790A (en) | 1989-03-09 | 1990-10-02 | University Of Kansas | Derivatives of taxol, pharmaceutical compositions thereof and methods for the preparation thereof |
| US5175315A (en) | 1989-05-31 | 1992-12-29 | Florida State University | Method for preparation of taxol using β-lactam |
| US5243253A (en) * | 1991-07-30 | 1993-09-07 | Thomson Consumer Electronics, Inc. | Color picture tube having shadow mask with improved tie bar grading |
| US5250683A (en) * | 1991-09-23 | 1993-10-05 | Florida State University | Certain substituted taxanes and pharmaceutical compositions containing them |
| US5283253A (en) | 1991-09-23 | 1994-02-01 | Florida State University | Furyl or thienyl carbonyl substituted taxanes and pharmaceutical compositions containing them |
| US5227400A (en) | 1991-09-23 | 1993-07-13 | Florida State University | Furyl and thienyl substituted taxanes and pharmaceutical compositions containing them |
| US5714513A (en) | 1991-09-23 | 1998-02-03 | Florida State University | C10 taxane derivatives and pharmaceutical compositions |
| US5430160A (en) | 1991-09-23 | 1995-07-04 | Florida State University | Preparation of substituted isoserine esters using β-lactams and metal or ammonium alkoxides |
| US5350866A (en) | 1991-09-23 | 1994-09-27 | Bristol-Myers Squibb Company | 10-desacetoxytaxol derivatives |
| US5721268A (en) | 1991-09-23 | 1998-02-24 | Florida State University | C7 taxane derivatives and pharmaceutical compositions containing them |
| US5243045A (en) | 1991-09-23 | 1993-09-07 | Florida State University | Certain alkoxy substituted taxanes and pharmaceutical compositions containing them |
| ES2230790T3 (es) | 1992-01-15 | 2005-05-01 | E.R. SQUIBB & SONS, INC. | Procedimientos enzimaticos para la resolucion de mezclas enantiomericas de compuestos utiles como intermedios en la preparacion de taxanos. |
| DE4302686C2 (de) | 1992-02-05 | 1994-12-15 | Bierther Hans Dietmar | Hochleistungsventil |
| FR2687150B1 (fr) | 1992-02-07 | 1995-04-28 | Rhone Poulenc Rorer Sa | Procede de preparation de derives du taxane. |
| US5272171A (en) | 1992-02-13 | 1993-12-21 | Bristol-Myers Squibb Company | Phosphonooxy and carbonate derivatives of taxol |
| US5939561A (en) | 1992-03-10 | 1999-08-17 | Rhone-Poulence Rorer S.A. | Process for the preparation of β-phenylisoserine and β-lactam and their analogues |
| US5200534A (en) | 1992-03-13 | 1993-04-06 | University Of Florida | Process for the preparation of taxol and 10-deacetyltaxol |
| IL108443A0 (en) * | 1993-01-29 | 1994-04-12 | Univ Florida State | C7 taxane derivatives and pharmaceutical compositions containing them |
| US5703247A (en) | 1993-03-11 | 1997-12-30 | Virginia Tech Intellectual Properties, Inc. | 2-Debenzoyl-2-acyl taxol derivatives and methods for making same |
| DK1227093T3 (da) * | 1993-03-22 | 2005-08-29 | Univ Florida State | Beta-lactamer, der kan anvendes til fremstilling af taxaner med en furyl- eller thienylsubstitueret sidekæde |
| US5350253A (en) * | 1993-03-24 | 1994-09-27 | John Cunningham | Method for supporting distribution means |
| IL109926A (en) | 1993-06-15 | 2000-02-29 | Bristol Myers Squibb Co | Methods for the preparation of taxanes and microorganisms and enzymes utilized therein |
| TW397866B (en) | 1993-07-14 | 2000-07-11 | Bristol Myers Squibb Co | Enzymatic processes for the resolution of enantiomeric mixtures of compounds useful as intermediates in the preparation of taxanes |
| WO1996013495A1 (en) * | 1994-10-28 | 1996-05-09 | The Research Foundation Of State University Of New York | Taxoid derivatives, their preparation and their use as antitumor agents |
| US5780653A (en) | 1995-06-07 | 1998-07-14 | Vivorx Pharmaceuticals, Inc. | Nitrophenyl, 10-deacetylated substituted taxol derivatives as dual functional cytotoxic/radiosensitizers |
| CA2231837A1 (en) | 1995-09-13 | 1997-03-20 | Florida State University | Radiosensitizing taxanes and their pharmaceutical preparations |
| US5767297A (en) * | 1997-02-05 | 1998-06-16 | Ensuiko Sugar Refining Co., Ltd. | Taxoid derivative and method of producing thereof |
| JP3786462B2 (ja) * | 1996-03-07 | 2006-06-14 | 塩水港精糖株式会社 | タキソイドの配糖化誘導体およびその製造方法 |
| IL126856A0 (en) | 1996-05-06 | 1999-09-22 | Univ Florida State | 1-Deoxy baccatin iii 1-deoxy taxol and 1-deoxy taxol analogs and method for the preparation thereof |
| US5780683A (en) * | 1996-09-11 | 1998-07-14 | Abb Lummus Global Inc. | Cyclohexane oxidation |
| US5811452A (en) | 1997-01-08 | 1998-09-22 | The Research Foundation Of State University Of New York | Taxoid reversal agents for drug-resistance in cancer chemotherapy and pharmaceutical compositions thereof |
| US5912264A (en) | 1997-03-03 | 1999-06-15 | Bristol-Myers Squibb Company | 6-halo-or nitrate-substituted paclitaxels |
| HU224589B1 (hu) | 1997-06-03 | 2005-11-28 | Ensuiko Sugar Refining Co., Ltd. | Taxoidszármazékok és eljárás előállításukra |
| US7288665B1 (en) | 1997-08-18 | 2007-10-30 | Florida State University | Process for selective derivatization of taxanes |
| US6136988A (en) | 1998-04-10 | 2000-10-24 | Hauser, Inc. | 7-hexanoyltaxol and methods for preparing the same |
| JP2003522169A (ja) * | 2000-02-02 | 2003-07-22 | フロリダ・ステイト・ユニバーシティ・リサーチ・ファウンデイション・インコーポレイテッド | 抗腫瘍剤としてのｃ７ヘテロ置換アセテートタキサン |
| EP1175414A1 (de) | 2000-02-02 | 2002-01-30 | Florida State University Research Foundation, Inc. | Taxanformulierungen mit verbesserter löslichkeit |
-
2001
- 2001-02-02 JP JP2001557861A patent/JP2003522169A/ja not_active Withdrawn
- 2001-02-02 KR KR1020017012589A patent/KR20010112393A/ko not_active Abandoned
- 2001-02-02 IL IL14564201A patent/IL145642A0/xx unknown
- 2001-02-02 CA CA002368534A patent/CA2368534A1/en not_active Withdrawn
- 2001-02-02 CN CN01800318A patent/CN1362957A/zh active Pending
- 2001-02-02 MX MXPA01009922A patent/MXPA01009922A/es active IP Right Grant
- 2001-02-02 US US09/776,393 patent/US6673833B2/en not_active Expired - Fee Related
- 2001-02-02 CZ CZ20013519A patent/CZ20013519A3/cs unknown
- 2001-02-02 HK HK03100169.2A patent/HK1047935A1/zh unknown
- 2001-02-02 AT AT01906965T patent/ATE413397T1/de not_active IP Right Cessation
- 2001-02-02 WO PCT/US2001/003600 patent/WO2001057029A1/en not_active Ceased
- 2001-02-02 BR BR0104353-6A patent/BR0104353A/pt not_active IP Right Cessation
- 2001-02-02 DE DE60136430T patent/DE60136430D1/de not_active Expired - Fee Related
- 2001-02-02 PL PL01350328A patent/PL350328A1/xx not_active Application Discontinuation
- 2001-02-02 HU HU0200651A patent/HUP0200651A3/hu unknown
- 2001-02-02 EP EP01906965A patent/EP1200424B1/de not_active Expired - Lifetime
- 2001-02-02 NZ NZ514411A patent/NZ514411A/en unknown
- 2001-02-02 AU AU34804/01A patent/AU776765B2/en not_active Ceased
- 2001-10-01 ZA ZA200108063A patent/ZA200108063B/en unknown
- 2001-10-01 NO NO20014758A patent/NO20014758L/no not_active Application Discontinuation
-
2003
- 2003-11-24 US US10/720,826 patent/US6861446B2/en not_active Expired - Fee Related
-
2005
- 2005-02-23 US US11/063,626 patent/US7183312B2/en not_active Expired - Fee Related
Also Published As
| Publication number | Publication date |
|---|---|
| MXPA01009922A (es) | 2003-07-14 |
| KR20010112393A (ko) | 2001-12-20 |
| WO2001057029A1 (en) | 2001-08-09 |
| CN1362957A (zh) | 2002-08-07 |
| PL350328A1 (en) | 2002-12-02 |
| EP1200424B1 (de) | 2008-11-05 |
| AU776765B2 (en) | 2004-09-23 |
| US6673833B2 (en) | 2004-01-06 |
| HUP0200651A3 (en) | 2002-10-28 |
| EP1200424A1 (de) | 2002-05-02 |
| NO20014758L (no) | 2001-11-29 |
| BR0104353A (pt) | 2002-04-16 |
| ZA200108063B (en) | 2003-12-01 |
| DE60136430D1 (de) | 2008-12-18 |
| HK1047935A1 (zh) | 2003-03-14 |
| US20050143446A1 (en) | 2005-06-30 |
| US20020065305A1 (en) | 2002-05-30 |
| NO20014758D0 (no) | 2001-10-01 |
| US7183312B2 (en) | 2007-02-27 |
| IL145642A0 (en) | 2002-06-30 |
| JP2003522169A (ja) | 2003-07-22 |
| CA2368534A1 (en) | 2001-08-09 |
| HUP0200651A2 (hu) | 2002-07-29 |
| US6861446B2 (en) | 2005-03-01 |
| AU3480401A (en) | 2001-08-14 |
| NZ514411A (en) | 2005-02-25 |
| CZ20013519A3 (cs) | 2002-04-17 |
| US20040087547A1 (en) | 2004-05-06 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ATE381328T1 (de) | Heterosubstituierte taxan-c10-acetate als antitumormittel | |
| MY137637A (en) | C7 ester substituted taxanes | |
| DOP2001000151A (es) | Derivados de imidazopirimidina y derivados de triazolopimidina. | |
| DK1131315T3 (da) | Polyhydroxylerede heterocykliske derivater som antikoagulanter | |
| DE60136430D1 (de) | Heterosubstituierte c7-taxanacetate als antitumormittel | |
| BG105964A (en) | C(10) carbonate substituted taxanes and their use as antitumor agents | |
| TR199701298T1 (xx) | Tetralinler. | |
| DE60134814D1 (de) | C10-carbamoyloxysubstituierte taxane als antitumormittel | |
| DE60138853D1 (de) | C10-taxanester als antitumormittel | |
| BG105966A (en) | C7 carbonate substituted taxanes and their application as antitumor agents | |
| ATE392422T1 (de) | C7-carbamoyloxysubstituierte taxane als antitumormittel | |
| NZ504614A (en) | Echinocandin derivatives and application as anti-fungal agents | |
| ATE282611T1 (de) | Stolonoxide | |
| DK1436277T3 (da) | Fremgangsmåde til fremstilling af 14beta-hydroxy-baccatin III-1,14-carbonat | |
| SG125888A1 (en) | C10 carbonate substituted taxanes | |
| BR0109394A (pt) | Compostos de esponja antitumores | |
| MXPA01007972A (es) | Esteres de taxanos c10 sustituidos. | |
| SG125889A1 (en) | C7 ester subsituted taxanes |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| RER | Ceased as to paragraph 5 lit. 3 law introducing patent treaties |